BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36146637)

  • 1. Intranasal Treatment of Ferrets with Inert Bacterial Spores Reduces Disease Caused by a Challenging H7N9 Avian Influenza Virus.
    James J; Meyer SM; Hong HA; Dang C; Linh HTY; Ferreira W; Katsande PM; Vo L; Hynes D; Love W; Banyard AC; Cutting SM
    Vaccines (Basel); 2022 Sep; 10(9):. PubMed ID: 36146637
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant virus-like particles elicit protective immunity against avian influenza A(H7N9) virus infection in ferrets.
    Liu YV; Massare MJ; Pearce MB; Sun X; Belser JA; Maines TR; Creager HM; Glenn GM; Pushko P; Smith GE; Tumpey TM
    Vaccine; 2015 Apr; 33(18):2152-8. PubMed ID: 25772674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plant-derived H7 VLP vaccine elicits protective immune response against H7N9 influenza virus in mice and ferrets.
    Pillet S; Racine T; Nfon C; Di Lenardo TZ; Babiuk S; Ward BJ; Kobinger GP; Landry N
    Vaccine; 2015 Nov; 33(46):6282-9. PubMed ID: 26432915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal H5N1 vaccines, adjuvanted with chitosan derivatives, protect ferrets against highly pathogenic influenza intranasal and intratracheal challenge.
    Mann AJ; Noulin N; Catchpole A; Stittelaar KJ; de Waal L; Veldhuis Kroeze EJ; Hinchcliffe M; Smith A; Montomoli E; Piccirella S; Osterhaus AD; Knight A; Oxford JS; Lapini G; Cox R; Lambkin-Williams R
    PLoS One; 2014; 9(5):e93761. PubMed ID: 24850536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low pathogenic avian influenza A(H7N9) virus causes high mortality in ferrets upon intratracheal challenge: a model to study intervention strategies.
    Kreijtz JH; Kroeze EJ; Stittelaar KJ; de Waal L; van Amerongen G; van Trierum S; van Run P; Bestebroer T; T Kuiken ; Fouchier RA; Rimmelzwaan GF; Osterhaus AD
    Vaccine; 2013 Oct; 31(43):4995-9. PubMed ID: 23816392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmissibility of novel H7N9 and H9N2 avian influenza viruses between chickens and ferrets.
    Ku KB; Park EH; Yum J; Kim HM; Kang YM; Kim JC; Kim JA; Kim HS; Seo SH
    Virology; 2014 Feb; 450-451():316-23. PubMed ID: 24503095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacillus subtilis spores as adjuvants against avian influenza H9N2 induce antigen-specific antibody and T cell responses in White Leghorn chickens.
    Lee JE; Kye YC; Park SM; Shim BS; Yoo S; Hwang E; Kim H; Kim SJ; Han SH; Park TS; Park BC; Yun CH
    Vet Res; 2020 May; 51(1):68. PubMed ID: 32448402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of H7N9 influenza A viruses isolated from humans.
    Watanabe T; Kiso M; Fukuyama S; Nakajima N; Imai M; Yamada S; Murakami S; Yamayoshi S; Iwatsuki-Horimoto K; Sakoda Y; Takashita E; McBride R; Noda T; Hatta M; Imai H; Zhao D; Kishida N; Shirakura M; de Vries RP; Shichinohe S; Okamatsu M; Tamura T; Tomita Y; Fujimoto N; Goto K; Katsura H; Kawakami E; Ishikawa I; Watanabe S; Ito M; Sakai-Tagawa Y; Sugita Y; Uraki R; Yamaji R; Eisfeld AJ; Zhong G; Fan S; Ping J; Maher EA; Hanson A; Uchida Y; Saito T; Ozawa M; Neumann G; Kida H; Odagiri T; Paulson JC; Hasegawa H; Tashiro M; Kawaoka Y
    Nature; 2013 Sep; 501(7468):551-5. PubMed ID: 23842494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single dose of whole inactivated H7N9 influenza vaccine confers protection from severe disease but not infection in ferrets.
    Wong SS; Jeevan T; Kercher L; Yoon SW; Petkova AM; Crumpton JC; Franks J; Debeauchamp J; Rubrum A; Seiler P; Krauss S; Webster R; Webby RJ
    Vaccine; 2014 Jul; 32(35):4571-4577. PubMed ID: 24950355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited airborne transmission of H7N9 influenza A virus between ferrets.
    Richard M; Schrauwen EJ; de Graaf M; Bestebroer TM; Spronken MI; van Boheemen S; de Meulder D; Lexmond P; Linster M; Herfst S; Smith DJ; van den Brand JM; Burke DF; Kuiken T; Rimmelzwaan GF; Osterhaus AD; Fouchier RA
    Nature; 2013 Sep; 501(7468):560-3. PubMed ID: 23925116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Single Amino Acid Substitution at Residue 218 of Hemagglutinin Improves the Growth of Influenza A(H7N9) Candidate Vaccine Viruses.
    Li X; Gao Y; Ye Z
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31270231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a high-yield live attenuated H7N9 influenza virus vaccine that provides protection against homologous and heterologous H7 wild-type viruses in ferrets.
    Chen Z; Baz M; Lu J; Paskel M; Santos C; Subbarao K; Jin H; Matsuoka Y
    J Virol; 2014 Jun; 88(12):7016-23. PubMed ID: 24719414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H5 N-terminal β sheet promotes oligomerization of H7-HA1 that induces better antibody affinity maturation and enhanced protection against H7N7 and H7N9 viruses compared to inactivated influenza vaccine.
    Khurana S; Coyle EM; Verma S; King LR; Manischewitz J; Crevar CJ; Carter DM; Ross TM; Golding H
    Vaccine; 2014 Nov; 32(48):6421-32. PubMed ID: 25284811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of 3 kinds of Toll-like receptor ligands for inactivated avian H5N1 influenza virus intranasal immunization in chicken.
    Liang J; Fu J; Kang H; Lin J; Yu Q; Yang Q
    Poult Sci; 2013 Oct; 92(10):2651-60. PubMed ID: 24046412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mouse and ferret models for studying the novel avian-origin human influenza A (H7N9) virus.
    Xu L; Bao L; Deng W; Zhu H; Chen T; Lv Q; Li F; Yuan J; Xiang Z; Gao K; Xu Y; Huang L; Li Y; Liu J; Yao Y; Yu P; Yong W; Wei Q; Zhang L; Qin C
    Virol J; 2013 Aug; 10():253. PubMed ID: 23927489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Hemagglutinin A Stem Antibody MEDI8852 Prevents and Controls Disease and Limits Transmission of Pandemic Influenza Viruses.
    Paules CI; Lakdawala S; McAuliffe JM; Paskel M; Vogel L; Kallewaard NL; Zhu Q; Subbarao K
    J Infect Dis; 2017 Aug; 216(3):356-365. PubMed ID: 28633457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel avian-origin human influenza A(H7N9) can be transmitted between ferrets via respiratory droplets.
    Xu L; Bao L; Deng W; Dong L; Zhu H; Chen T; Lv Q; Li F; Yuan J; Xiang Z; Gao K; Xu Y; Huang L; Li Y; Liu J; Yao Y; Yu P; Li X; Huang W; Zhao X; Lan Y; Guo J; Yong W; Wei Q; Chen H; Zhang L; Qin C
    J Infect Dis; 2014 Feb; 209(4):551-6. PubMed ID: 23990570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Monoclonal Antibody 81.39a Effectively Neutralizes Emerging Influenza A Viruses of Group 1 and 2 Hemagglutinins.
    Marjuki H; Mishin VP; Chai N; Tan MW; Newton EM; Tegeris J; Erlandson K; Willis M; Jones J; Davis T; Stevens J; Gubareva LV
    J Virol; 2016 Dec; 90(23):10446-10458. PubMed ID: 27630240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant baculovirus vaccine expressing hemagglutinin of H7N9 avian influenza virus confers full protection against lethal highly pathogenic H7N9 virus infection in chickens.
    Hu J; Liang Y; Hu Z; Wang X; Gu M; Li R; Ma C; Liu X; Hu S; Chen S; Peng D; Jiao X; Liu X
    Arch Virol; 2019 Mar; 164(3):807-817. PubMed ID: 30671655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo prophylactic activity of QR-435 against H3N2 influenza virus infection.
    Oxford JS; Lambkin R; Guralnik M; Rosenbloom RA; Petteruti MP; Digian K; LeFante C
    Am J Ther; 2007; 14(5):462-8. PubMed ID: 17890936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.